- Print ISSN
- Electronic ISSN
- Impact factor
- Usage rank
- Article count
- Free count
- Free percentage
- PDFs via platforms
- Gale, Ingenta, Rcgp, and Sciencedirect from 1995
Exploring the Therapeutic Rationale for Angiogenesis Blockade in Cervical Cancer
Purpose This review highlights the molecular and pathologic evidence that cervical cancer is driven by angiogenesis and presents a summary of the recent clinical research in antiangiogenesis therapy for advanced cervical cancer with a focus on the use of bevacizumab.
Assessing Pharmacokinetic Interactions Between the Sodium Glucose Cotransporter 2 Inhibitor Empagliflozin and Hydrochlorothiazide or Torasem...
Clinical Therapeutics (2012)Purpose Empagliflozin is a potent, selective sodium glucose cotransporter 2 inhibitor approved for the treatment of type 2 diabetes mellitus. Thiazide or loop diuretics are commonly prescribed in patients with type 2 diabetes mellitus. This study investigated potential pharmacoki...
Genotype-Phenotype Correlations in Pompe Disease
Diagnosis by Electron Microscopy of Late Onset Pompe Disease with Previous Normal or Non Specific Muscle Biopsies by Light Microscopy
Genetics and epidemiology of Pompe disease
Clinical Therapeutics 32:0 (2010)
Comparing two cost-effectiveness studies of statins for the primary prevention of cardiovascular disease: Are statins cost-effective from a ...
Improving compliance and quality of life with home infusions for the treatment of fabry disease
Clinical Therapeutics 31:0 (2009)